Personalized Cancer Vaccines: A New Frontier in Treating Glioblastoma Glioblastoma remains one of the most challenging diagnoses in oncology. As an aggressive form of brain cancer, it is notoriously resistant …
glioblastoma
-
-
Scientists have uncovered a “hidden vulnerability” involving vitamin B in one of the most aggressive forms of brain cancer, which means a specialised diet could help slow tumour growth. The …
-
Summary of UVA health System News Release: Potential New Glioblastoma Treatment Discovered Key Takeaways: * New Target Identified: Researchers at the University of Virginia (UVA) have identified the AVIL gene …
-
“`html New Immune Cell Therapy Trial for Refractory Glioblastoma New Hope for Glioblastoma Patients: Clinical Trial of Combined Immune Cell Therapy Announced Table of Contents New Hope for Glioblastoma Patients: …
-
“`html RNA Cocktail Shows Promise Against Brain Tumors RNA Cocktail Shows Promise Against Brain Tumors Table of Contents RNA Cocktail Shows Promise Against Brain Tumors Understanding Glioblastoma and the Need …
-
Understanding Brain tumor Behaviour: A New Approach to Mechanical Force Measurement Brain tumors present a complex challenge, and their growth patterns significantly impact patient outcomes. As these tumors develop,they employ …
-
Technology
The Role of the Subventricular Zone in Neural Regeneration and Neurodegenerative Diseases
Unlocking the Potential of the Subventricular Zone in Neurological Health The subventricular zone (SVZ), an area within the adult brain, is garnering significant attention for its critical role in neural …
-
Glioblastoma’s Internal Clock: Timing Treatments May Hold the Key to Improved Outcomes Glioblastoma, a deadly and aggressive brain cancer, appears to have an internal clock that synchronizes with the body’s …
-
Brain Tumor Organoids: Revolutionizing CAR T-cell Therapy for Glioblastoma Glioblastoma (GBM) is the most common and aggressive type of cancerous brain tumor in adults, with a dismal prognosis of just …
-
Health
Terms of Service Agreements. Researchers awarded Synergy Grant to target tumor vessels and boost immunotherapy
Targeting Tumor Blood Vessels: A New Frontier in Cancer Therapy A groundbreaking project called VASC-IMMUNE, recently awarded a prestigious Synergy Grant by the European Research Council, aims to revolutionize cancer …